3-38604023-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP2
The NM_000335.5(SCN5A):c.1579G>A(p.Gly527Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000459 in 1,611,594 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000335.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.1579G>A | p.Gly527Arg | missense_variant | Exon 12 of 28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.1579G>A | p.Gly527Arg | missense_variant | Exon 12 of 28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.1579G>A | p.Gly527Arg | missense_variant | Exon 12 of 28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.1579G>A | p.Gly527Arg | missense_variant | Exon 12 of 28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000328 AC: 8AN: 243942Hom.: 0 AF XY: 0.0000378 AC XY: 5AN XY: 132434
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1459430Hom.: 0 Cov.: 32 AF XY: 0.0000510 AC XY: 37AN XY: 725768
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74334
ClinVar
Submissions by phenotype
not provided Uncertain:3
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25650408, 27321809) -
Variant summary: The SCN5A c.1579G>A (p.Gly527Arg) variant involves the alteration of a non-conserved nucleotide. This variant is located in the voltage-gated Na+ ion channel cytoplasmic domain (InterPro). 3/3 in silico tools predict a damaging outcome for this variant. This variant was found in 4/90200 control chromosomes at a frequency of 0.0000443, which is approximately 2 times the estimated maximal expected allele frequency of a pathogenic SCN5A variant (0.000025), suggesting this variant is possibly a benign polymorphism. However, with only four heterozygotes in ExAC it is uncertain whether this variant is benign as the phenotypes linked with this gene is often silent and has a variable age of onset and the pathogenic variants in this gene could have a reduced penetrance. The variant of interest has been reported in at least 1 affected individual without strong evidence for causality (Kapoor, 2016) and in 1 unaffected control from case-control studiy (Le Scouarnec,2015). It has been reported in a kidney carcinoma sample (Pickering CR et al 2014) and a skin carcinoma sample as a somatic occurrence (COSMIC). The variant has not been evaluated for functional impact by in vivo/vitro studies. Additional supporting evidence needed to classify this variant with confidence. Taken together, this variant is classified as variant of uncertain significance. -
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 527 of the SCN5A protein (p.Gly527Arg). This variant is present in population databases (rs763550164, gnomAD 0.02%). This missense change has been observed in individual(s) with SCN5A-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 406447). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiac arrhythmia Uncertain:2
This missense variant replaces glycine with arginine at codon 527 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with Brugada syndrome (PMID: 32268277), an individual suspected of having Brugada syndrome (PMID: 29309564), and an individual suspected of having epilepsy (PMID: 31696929). This variant has also been identified in 8/243942 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This missense variant replaces glycine with arginine at codon 527 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with Brugada syndrome (PMID: 32268277), an individual suspected of having Brugada syndrome (PMID: 29309564), and an individual suspected of having epilepsy (PMID: 31696929). This variant has also been identified in 8/243942 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.G527R variant (also known as c.1579G>A), located in coding exon 11 of the SCN5A gene, results from a G to A substitution at nucleotide position 1579. The glycine at codon 527 is replaced by arginine, an amino acid with dissimilar properties. This variant has been detected in individuals from cohorts with various phenotypes including suspected Brugada syndrome, suspected epilepsy, and spastic ataxia; however, clinical details were limited and some cases had additional variants in SCN5A or other genes (Lu Q et al. Ann Transl Med, 2020 Jan;8:8; Campuzano O et al. EBioMedicine, 2020 Apr;54:102732; Li X et al. Ann Hum Genet, 2020 03;84:161-168; Pablo Flórez J et al. Europace, 2018 06;20:f64-f71). This variant has also been detected in a control cohort and a study of variants associated with QT interval; however, details were limited (Kapoor A et al. Sci Rep, 2016 06;6:28356; Le Scouarnec S et al. Hum Mol Genet, 2015 May;24:2757-63). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at